Comparison of CMV antigenaemia and quantitative realtime PCR CMV-DNA assay in the detection of CMV infection in patients after allogeneic haematopoietic stem cell transplantation

被引：0
|
作者：
Gozdzik, J. [1 ]
Mordel, A. [1 ]
Lesko, E. [1 ]
Krasowska-Kwiecien, A. [1 ]
Kacinska, E. [1 ]
Wedrychowicz, A. [1 ]
Czogala, W. [1 ]
Wiecha, O. [1 ]
Skoczen, S. [1 ]
Majka, M. [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [41] Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation
    Hebart, H
    Rudolph, T
    Loeffler, J
    Middeldorp, J
    Ljubicic, T
    Jahn, G
    Einsele, H
    [J]. BONE MARROW TRANSPLANTATION, 2002, 30 (03) : 181 - 187
  • [42] Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation
    H Hebart
    T Rudolph
    J Loeffler
    J Middeldorp
    T Ljubicic
    G Jahn
    H Einsele
    [J]. Bone Marrow Transplantation, 2002, 30 : 181 - 187
  • [43] CMV infection and disease after allogeneic stem cell transplantation with reduced-intensity conditioning
    Avetisyan, G.
    Hagglund, H.
    Hassan, Z.
    LeBlanc, K.
    Mattsson, J.
    Ringden, O.
    Winiarski, J.
    Ljungman, P.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S241 - S242
  • [44] PROPHYLAXIS OF CMV INFECTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH NILOTINIB : A PHASE II TRIAL
    Lin, C. T.
    Wu, S. J.
    Li, C. C.
    Ko, B. S.
    Yao, M.
    Lin, W. P.
    Tang, J. L.
    Tien, H. F.
    [J]. HAEMATOLOGICA, 2014, 99 : 423 - 423
  • [45] Valganciclovir for the early prophylaxis of cytomegalovirus (CMV) infection after allogeneic stem cell transplantation.
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    [J]. BLOOD, 2004, 104 (11) : 352B - 352B
  • [46] An experimental and clinical study of CMV infection after allogeneic hematopoietic stem cell transplantation.
    Wu, DP
    Wu, XJ
    Li, CX
    Ma, X
    Sun, AN
    [J]. BLOOD, 2004, 104 (11) : 354B - 354B
  • [47] CMV infection plays a crucial role in the immune reconstitution after allogeneic stem cell transplantation
    Hartjen, A. S.
    Krumbholz, A.
    Thieme, F.
    Bulduk, M.
    Humpe, A.
    Gramatzki, M.
    Guenther, A.
    [J]. Oncology Research and Treatment, 2015, 38 : 45 - 45
  • [48] CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath
    Bainton, RD
    Byrne, JL
    Davy, BJ
    Russell, NH
    [J]. BLOOD, 2002, 100 (10) : 3843 - 3844
  • [49] Immunologic Monitoring after Allogeneic Stem Cell Transplantation: T-SPOT.CMV and QuantiFERON-CMV, Are They the Same?
    Callens, Rutger
    Colman, Sofie
    Delie, Anke
    Schauwvlieghe, Alexander
    Lodewyck, Tom
    Selleslag, Dominik
    Reynders, Marijke
    Kerre, Tessa
    Padalko, Elizaveta
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 392.e1 - 392.e7
  • [50] Quantitative CMV PCR in allogenic stem-cell transplant patients
    Portocarrero, N.
    Moriente, A.
    Monclus, D.
    Lomas, E.
    Sanchez, P.
    Sanchez, C.
    Cardenoso, L.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S150 - S150
12345